Division of Gastroenterology-Hepatology, Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
Division of Gastroenterology-Hepatology, Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
Clin Gastroenterol Hepatol. 2023 Sep;21(10):2660-2669. doi: 10.1016/j.cgh.2023.01.017. Epub 2023 Jan 31.
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is associated with substantial costs to society. Extensive data on direct costs (health care consumption) and indirect costs (health-related productivity loss) are lacking. Hence, we examined the socioeconomic costs of IBS and assessed which patient characteristics are associated with higher costs.
Cross-sectional data from 3 Rome-defined Dutch IBS patient cohorts (n = 419) were collected. Bootstrapped mean direct and indirect costs were evaluated per patient with IBS using validated questionnaires (ie, medical cost questionnaire and productivity cost questionnaire, respectively). Multivariable regression analyses were performed to identify variables associated with higher costs.
Quarterly mean total costs per patient were €2.156 (95% confidence interval (CI), €1793-€2541 [$2444]), consisting of €802 (95% CI, €625-€1010 [$909]) direct costs and €1.354 (95% CI, €1072-€1670 [$1535]) indirect costs. Direct costs consisted primarily of health care professional consultations, with costs related to gastrointestinal clinic visits accounting for 6% and costs related to mental health care visits for 20%. Higher direct costs were significantly associated with older age (P = .007), unemployment (P = .001), IBS subtypes other than constipation (P = .033), lower disease-specific quality of life (P = .027), and more severe depressive symptoms (P = .001). Indirect costs consisted of absenteeism (45%), presenteeism (42%), and productivity loss related to unpaid labor (13%) and were significantly associated with the male sex (P = .014) and more severe depressive symptoms (P = .047).
Productivity loss is the main contributor to the socioeconomic burden of IBS. Direct costs were not predominantly related to gastrointestinal care, but rather to mental health care. Awareness of the nature of costs and contributing patient factors should lead to significant socioeconomic benefits for society.
肠易激综合征(IBS)给社会带来了巨大的经济负担。目前缺乏关于直接成本(医疗保健消费)和间接成本(与健康相关的生产力损失)的广泛数据。因此,我们研究了 IBS 的社会经济学成本,并评估了哪些患者特征与更高的成本相关。
收集了 3 个罗马定义的荷兰 IBS 患者队列(n=419)的横断面数据。使用经过验证的问卷(即医疗费用问卷和生产力费用问卷)分别评估每位 IBS 患者的直接和间接平均成本。进行多变量回归分析以确定与更高成本相关的变量。
每位患者的季度平均总成本为 2156 欧元(95%置信区间[CI],1793-2541 欧元),包括 802 欧元(95%CI,625-1010 欧元)直接成本和 1354 欧元(95%CI,1072-1670 欧元)间接成本。直接成本主要包括卫生保健专业人员的咨询费用,其中与胃肠道诊所就诊相关的费用占 6%,与心理健康护理就诊相关的费用占 20%。更高的直接成本与年龄较大(P=0.007)、失业(P=0.001)、非便秘型 IBS 亚型(P=0.033)、较低的疾病特异性生活质量(P=0.027)和更严重的抑郁症状(P=0.001)显著相关。间接成本包括旷工(45%)、在职病假(42%)以及与无薪劳动相关的生产力损失(13%),与男性性别(P=0.014)和更严重的抑郁症状(P=0.047)显著相关。
生产力损失是 IBS 社会经济学负担的主要原因。直接成本主要与心理健康护理相关,而不是与胃肠道护理相关。了解成本的性质和导致成本增加的患者因素,应该会给社会带来显著的社会经济效益。